CONMED Undergoes Significant Russell Index Rebalancing

CNMD
September 18, 2025
CONMED Corporation experienced a notable rebalancing within the Russell Indices, resulting in its removal from several growth-focused categories. The company was dropped from indices such as the Russell 2000 Dynamic Index, Russell 3000 Growth Index, and Russell 2500 Growth Index. Concurrently, CONMED was added to multiple value-oriented indices, including the Russell 3000 Value Index, Russell 2000 Value-Defensive Index, and Russell 2500 Value Index. This shift indicates a reclassification of CONMED's investment profile by the index provider. This reclassification can influence institutional investment flows, as many funds are mandated to track specific growth or value indices. The change may lead to adjustments in portfolio holdings by passive and active funds, potentially impacting the company's shareholder base and trading characteristics. The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.